Growth factor mediating many of GH’s effects on tissues including hair follicles. WADA-prohibited. Systemic administration carries hypoglycemia risk—follicle-level delivery remains an unsolved problem.

📖 Read the full IGF-1 (Hair) research overview →

Evidence Tier: Tier 3 — Pilot / Limited Human Data · Peptidings Verdict: Eyes Open